Whole plasmid sequencing is a genome sequencing method based on the second-generation high-throughput sequencing technology, which aims to construct a library and sequence the whole genome of the plasmid.
The global Whole Plasmid Sequencing market was valued at US$ 17.6 million in 2023 and is anticipated to reach US$ 29.9 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
North American market for Whole Plasmid Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Whole Plasmid Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Whole Plasmid Sequencing in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Whole Plasmid Sequencing include Eurofins Genomics, GenScript, Plasmidsaurus, Genewiz, Macrogen Europe, Source BioScience, Psomagen, BaseClear B.V., Molecular Cloning Laboratories (MCLAB), Polyplus, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Whole Plasmid Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Plasmid Sequencing.
The Whole Plasmid Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Whole Plasmid Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whole Plasmid Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Eurofins Genomics
GenScript
Plasmidsaurus
Genewiz
Macrogen Europe
Source BioScience
Psomagen
BaseClear B.V.
Molecular Cloning Laboratories (MCLAB)
Polyplus
Elim Biopharm
SnapGene
Full Circle Labs
Unveil Bio
Segment by Type
Plasmid Regular (2.5 鈥� 25 kb)
Plasmid Large (25 鈥� 125 kb)
Plasmid XL (125 鈥� 300 kb)
Others
Segment by Application
Biopharmaceutical Companies
Research Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Whole Plasmid Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Whole Plasmid Sequencing 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plasmid Regular (2.5 鈥� 25 kb)
1.2.3 Plasmid Large (25 鈥� 125 kb)
1.2.4 Plasmid XL (125 鈥� 300 kb)
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Whole Plasmid Sequencing 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Plasmid Sequencing 麻豆原创 Perspective (2019-2030)
2.2 Global Whole Plasmid Sequencing Growth Trends by Region
2.2.1 Global Whole Plasmid Sequencing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Whole Plasmid Sequencing Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Whole Plasmid Sequencing Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Whole Plasmid Sequencing 麻豆原创 Dynamics
2.3.1 Whole Plasmid Sequencing Industry Trends
2.3.2 Whole Plasmid Sequencing 麻豆原创 Drivers
2.3.3 Whole Plasmid Sequencing 麻豆原创 Challenges
2.3.4 Whole Plasmid Sequencing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Plasmid Sequencing Players by Revenue
3.1.1 Global Top Whole Plasmid Sequencing Players by Revenue (2019-2024)
3.1.2 Global Whole Plasmid Sequencing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Whole Plasmid Sequencing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Whole Plasmid Sequencing Revenue
3.4 Global Whole Plasmid Sequencing 麻豆原创 Concentration Ratio
3.4.1 Global Whole Plasmid Sequencing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Plasmid Sequencing Revenue in 2023
3.5 Global Key Players of Whole Plasmid Sequencing Head office and Area Served
3.6 Global Key Players of Whole Plasmid Sequencing, Product and Application
3.7 Global Key Players of Whole Plasmid Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Plasmid Sequencing Breakdown Data by Type
4.1 Global Whole Plasmid Sequencing Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Whole Plasmid Sequencing Forecasted 麻豆原创 Size by Type (2025-2030)
5 Whole Plasmid Sequencing Breakdown Data by Application
5.1 Global Whole Plasmid Sequencing Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Whole Plasmid Sequencing Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Whole Plasmid Sequencing 麻豆原创 Size (2019-2030)
6.2 North America Whole Plasmid Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Whole Plasmid Sequencing 麻豆原创 Size by Country (2019-2024)
6.4 North America Whole Plasmid Sequencing 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Whole Plasmid Sequencing 麻豆原创 Size (2019-2030)
7.2 Europe Whole Plasmid Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Whole Plasmid Sequencing 麻豆原创 Size by Country (2019-2024)
7.4 Europe Whole Plasmid Sequencing 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Whole Plasmid Sequencing 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Whole Plasmid Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Whole Plasmid Sequencing 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Whole Plasmid Sequencing 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Whole Plasmid Sequencing 麻豆原创 Size (2019-2030)
9.2 Latin America Whole Plasmid Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Whole Plasmid Sequencing 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Whole Plasmid Sequencing 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Plasmid Sequencing 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Whole Plasmid Sequencing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Whole Plasmid Sequencing 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Whole Plasmid Sequencing 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Genomics
11.1.1 Eurofins Genomics Company Details
11.1.2 Eurofins Genomics Business Overview
11.1.3 Eurofins Genomics Whole Plasmid Sequencing Introduction
11.1.4 Eurofins Genomics Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.1.5 Eurofins Genomics Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript Whole Plasmid Sequencing Introduction
11.2.4 GenScript Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.2.5 GenScript Recent Development
11.3 Plasmidsaurus
11.3.1 Plasmidsaurus Company Details
11.3.2 Plasmidsaurus Business Overview
11.3.3 Plasmidsaurus Whole Plasmid Sequencing Introduction
11.3.4 Plasmidsaurus Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.3.5 Plasmidsaurus Recent Development
11.4 Genewiz
11.4.1 Genewiz Company Details
11.4.2 Genewiz Business Overview
11.4.3 Genewiz Whole Plasmid Sequencing Introduction
11.4.4 Genewiz Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.4.5 Genewiz Recent Development
11.5 Macrogen Europe
11.5.1 Macrogen Europe Company Details
11.5.2 Macrogen Europe Business Overview
11.5.3 Macrogen Europe Whole Plasmid Sequencing Introduction
11.5.4 Macrogen Europe Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.5.5 Macrogen Europe Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Whole Plasmid Sequencing Introduction
11.6.4 Source BioScience Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.6.5 Source BioScience Recent Development
11.7 Psomagen
11.7.1 Psomagen Company Details
11.7.2 Psomagen Business Overview
11.7.3 Psomagen Whole Plasmid Sequencing Introduction
11.7.4 Psomagen Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.7.5 Psomagen Recent Development
11.8 BaseClear B.V.
11.8.1 BaseClear B.V. Company Details
11.8.2 BaseClear B.V. Business Overview
11.8.3 BaseClear B.V. Whole Plasmid Sequencing Introduction
11.8.4 BaseClear B.V. Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.8.5 BaseClear B.V. Recent Development
11.9 Molecular Cloning Laboratories (MCLAB)
11.9.1 Molecular Cloning Laboratories (MCLAB) Company Details
11.9.2 Molecular Cloning Laboratories (MCLAB) Business Overview
11.9.3 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Introduction
11.9.4 Molecular Cloning Laboratories (MCLAB) Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.9.5 Molecular Cloning Laboratories (MCLAB) Recent Development
11.10 Polyplus
11.10.1 Polyplus Company Details
11.10.2 Polyplus Business Overview
11.10.3 Polyplus Whole Plasmid Sequencing Introduction
11.10.4 Polyplus Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.10.5 Polyplus Recent Development
11.11 Elim Biopharm
11.11.1 Elim Biopharm Company Details
11.11.2 Elim Biopharm Business Overview
11.11.3 Elim Biopharm Whole Plasmid Sequencing Introduction
11.11.4 Elim Biopharm Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.11.5 Elim Biopharm Recent Development
11.12 SnapGene
11.12.1 SnapGene Company Details
11.12.2 SnapGene Business Overview
11.12.3 SnapGene Whole Plasmid Sequencing Introduction
11.12.4 SnapGene Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.12.5 SnapGene Recent Development
11.13 Full Circle Labs
11.13.1 Full Circle Labs Company Details
11.13.2 Full Circle Labs Business Overview
11.13.3 Full Circle Labs Whole Plasmid Sequencing Introduction
11.13.4 Full Circle Labs Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.13.5 Full Circle Labs Recent Development
11.14 Unveil Bio
11.14.1 Unveil Bio Company Details
11.14.2 Unveil Bio Business Overview
11.14.3 Unveil Bio Whole Plasmid Sequencing Introduction
11.14.4 Unveil Bio Revenue in Whole Plasmid Sequencing Business (2019-2024)
11.14.5 Unveil Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Eurofins Genomics
GenScript
Plasmidsaurus
Genewiz
Macrogen Europe
Source BioScience
Psomagen
BaseClear B.V.
Molecular Cloning Laboratories (MCLAB)
Polyplus
Elim Biopharm
SnapGene
Full Circle Labs
Unveil Bio
听
听
*If Applicable.
